Literature DB >> 6480029

Gene and haplotype frequencies of the fourth component of complement (C4) in type 1 diabetics and normal controls.

J Bertrams, U Hintzen, V Schlicht, S Schoeps, F A Gries, T K Louton, M P Baur.   

Abstract

C4 gene and haplotype frequencies were calculated from phenotype data of 380 unrelated Caucasian patients with insulin dependent (type 1) diabetes mellitus and were compared with analogous frequencies of 382 unrelated healthy Caucasian individuals. In diabetics, a significantly increased frequency of the rare allele C4B 3 (p less than 10(-7] and of the silent alleles C4A Q0 (p less than 10(-7] and B Q0 (p less than 0.002) was observed. Accordingly, insulin dependent diabetes is associated with partial C4 deficiency, which may contribute to the pathogenesis of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480029     DOI: 10.1016/S0171-2985(84)80012-1

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  5 in total

1.  Defective prevention of immune precipitation in autoimmune diseases is independent of C4A*Q0.

Authors:  G J Arason; R Kolka; A B Hreidarsson; H Gudjonsson; P M Schneider; L Fry; A Arnason
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

2.  Contrasting evolutionary histories among tightly linked HLA loci.

Authors:  W Klitz; G Thomson; M P Baur
Journal:  Am J Hum Genet       Date:  1986-09       Impact factor: 11.025

3.  Differences in the metabolism of C4 isotypes in patients with complement activation.

Authors:  P W Peake; B A Pussell; J A Charlesworth; L Gavrilovic; V Timmermans
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

4.  A marked drop in the incidence of the null allele of the B gene of the fourth component of complement (C4B*Q0) in elderly subjects: C4B*Q0 as a probable negative selection factor for survival.

Authors:  J Kramer; T Fülöp; K Rajczy; A T Nguyen; G Füst
Journal:  Hum Genet       Date:  1991-04       Impact factor: 4.132

5.  C4 uremic variant: an acquired C4 allotype.

Authors:  T R Welch; L Beischel
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.